Skip to NavigationSkip to content

News

0
Roche revealed strong data on its cancer immunotherapy Tecentriq in combination with chemotherapy in the first-line treatment of previously...
0
Japanese pharma firm Takeda has announced that the gut-selective biologic vedolizumab when taken as a subcutaneous (SC) injection, proved...
0
Janssen has revealed new long-term data for its IL-23 inhibitor Tremfya (guselkumab) in moderate to severe plaque psoriasis, demonstrating skin...
0
American pharma firm Bristol-Myers Squibb have announced that more than 53% of patients with advanced melanoma, who were treated with Opdivo in...

Features

It really is about having a dream and figuring out how to go about accomplishing that dream”